Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 2:35 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 532878 | NSE: ALPA

Alpa Laboratories Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹77.27Undervalued by 53.92%vs CMP ₹50.20

P/E (9.0) × ROE (11.5%) × BV (₹92.00) × DY (2.00%)

₹71.07Undervalued by 41.57%vs CMP ₹50.20
MoS: +29.4% (Adequate)Confidence: 58/100 (Moderate)Models: 7 Under, 1 Fair, 1 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹74.5323%Under (+48.5%)
Graham NumberEarnings₹107.7616%Under (+114.7%)
Earnings PowerEarnings₹65.4911%Under (+30.5%)
DCFCash Flow₹56.8914%Under (+13.3%)
Net Asset ValueAssets₹91.887%Under (+83%)
EV/EBITDAEnterprise₹25.579%Over (-49.1%)
Earnings YieldEarnings₹56.107%Under (+11.8%)
ROCE CapitalReturns₹77.897%Under (+55.2%)
Revenue MultipleRevenue₹52.095%Fair (+3.8%)
Consensus (9 models)₹71.07100%Undervalued
Key Drivers: Wide model spread (₹26–₹108) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -3.5%

*Investments are subject to market risks

Investment Snapshot

55
Alpa Laboratories Ltd scores 55/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health72/100 · Strong
ROCE 15.0% GoodROE 11.5% AverageD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money50/100 · Moderate
FII holding stable No changePromoter holding at 57.3% Stable
Earnings Quality50/100 · Moderate
OPM stable around 7% Steady
Quarterly Momentum40/100 · Moderate
Revenue (4Q): +13% YoY GrowingProfit (4Q): -10% YoY DecliningOPM: -11.2% (down 24.3% YoY) Margin pressure
Industry Rank55/100 · Moderate
P/E 9.0 vs industry 53.8 Cheaper than peersROCE 15.0% vs industry 16.4% Average3Y sales CAGR: -1% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 2:35 am

Market Cap 106 Cr.
Current Price 50.2
Intrinsic Value₹71.07
High / Low 120/46.0
Stock P/E8.95
Book Value 92.0
Dividend Yield0.00 %
ROCE15.0 %
ROE11.5 %
Face Value 10.0
PEG Ratio-2.52

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Alpa Laboratories Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Alpa Laboratories Ltd 106 Cr. 50.2 120/46.08.95 92.00.00 %15.0 %11.5 % 10.0
Lactose (India) Ltd 106 Cr. 84.2 137/76.021.9 49.60.00 %12.9 %9.69 % 10.0
Bal Pharma Ltd 103 Cr. 64.9 129/59.712.7 49.21.85 %10.1 %9.66 % 10.0
Par Drugs & Chemicals Ltd 102 Cr. 82.6 122/78.07.31 86.50.00 %18.4 %13.6 % 10.0
Pharmaids Pharmaceuticals Ltd 101 Cr. 28.6 73.4/27.1 14.70.00 %17.4 %16.3 % 10.0
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Alpa Laboratories Ltd

Quarterly Result

MetricSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales 13.5427.3129.1625.4332.3927.3123.6121.4424.9426.1539.1119.1125.63
Expenses 19.2824.6819.9026.5829.0724.8520.1020.9021.6725.4139.4718.6928.50
Operating Profit -5.742.639.26-1.153.322.463.510.543.270.74-0.360.42-2.87
OPM % -42.39%9.63%31.76%-4.52%10.25%9.01%14.87%2.52%13.11%2.83%-0.92%2.20%-11.20%
Other Income 6.382.69-0.764.472.953.553.975.186.918.803.2411.963.69
Interest 0.080.070.040.020.040.030.300.050.060.100.050.050.05
Depreciation 0.360.100.530.280.490.660.520.540.530.550.580.550.67
Profit before tax 0.205.157.933.025.745.326.665.139.598.892.2511.780.10
Tax % -0.00%-0.00%41.74%-0.00%-0.00%14.85%46.70%-0.00%20.44%-0.00%186.67%-0.00%-0.00%
Net Profit 0.205.144.623.035.744.533.555.127.638.89-1.9511.780.10
EPS in Rs 0.102.442.201.442.732.151.692.433.634.23-0.935.600.05

Last Updated: February 6, 2026, 6:47 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 18, 2026, 6:46 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 565753636277859711293109110114
Expenses 515447565776799010185100105114
Operating Profit 6377416811895-1
OPM % 10%6%13%11%7%2%7%8%10%9%8%5%-1%
Other Income 12645504119142319
Interest 2212110000000
Depreciation 9611111121222
Profit before tax -5-3119755112016212616
Tax % 4%-48%27%34%27%36%20%33%28%21%19%24%
Net Profit -5-18653471413172012
EPS in Rs -2.45-0.673.682.852.271.401.943.456.726.007.989.355.61
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)80.00%900.00%-25.00%-16.67%-40.00%33.33%75.00%100.00%-7.14%30.77%17.65%
Change in YoY Net Profit Growth (%)0.00%820.00%-925.00%8.33%-23.33%73.33%41.67%25.00%-107.14%37.91%-13.12%

Alpa Laboratories Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:7%
5 Years:6%
3 Years:0%
TTM:4%
Compounded Profit Growth
10 Years:55%
5 Years:30%
3 Years:36%
TTM:39%
Stock Price CAGR
10 Years:19%
5 Years:27%
3 Years:15%
1 Year:-8%
Return on Equity
10 Years:7%
5 Years:9%
3 Years:11%
Last Year:11%

Last Updated: September 4, 2025, 11:00 pm

Balance Sheet

Last Updated: January 7, 2026, 3:21 pm

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 21212121212121212121212121
Reserves 6766737782858996111124141161173
Borrowings 23292411620063502
Other Liabilities 15132720172121332830255152
Total Liabilities 127128145129127129131150165178192233248
Fixed Assets 73555666797112121
CWIP 0000001200000
Investments 0102223415968628690109129157
Other Assets 54113118100796456807081728370
Total Assets 127128145129127129131150165178192233248

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 8-2-25-8-7-118-1210418
Cash from Investing Activity + -237-71-16-15-116-161-13-12
Cash from Financing Activity + 47-6-24-5-1-05-32-5
Net Cash Flow 1042-37-9-19-2054-88-70
Free Cash Flow 6-3-25-10-9-215-409-37
CFO/OP 146%-92%-320%-71%-133%116%316%18%54%171%85%445%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-17.00-26.00-17.00-4.00-2.00-1.006.008.005.005.004.005.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 130156234169151141105133124186138155
Inventory Days 148761961311401059010281847392
Days Payable 121912441401309998152781006397
Cash Conversion Cycle 1571411871601611489783127170149150
Working Capital Days 65-4224197204189121137124150132108
ROCE %-3%0%10%11%7%4%7%7%9%11%14%15%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 57.29%57.29%57.29%57.29%57.29%57.29%57.29%57.29%57.29%57.29%57.29%57.29%
FIIs 0.00%0.00%0.11%0.95%0.50%0.36%0.74%0.35%0.40%0.36%0.35%0.36%
DIIs 0.01%0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public 42.70%42.70%42.59%41.74%42.21%42.35%41.97%42.34%42.30%42.34%42.36%42.35%
No. of Shareholders 19,13718,74518,56518,68218,69018,11618,88519,20618,87218,85118,54218,236

Shareholding Pattern Chart

No. of Shareholders

Alpa Laboratories Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 9.348.015.886.703.44
Diluted EPS (Rs.) 9.348.015.886.703.44
Cash EPS (Rs.) 10.328.906.617.484.03
Book Value[Excl.RevalReserv]/Share (Rs.) 81.4872.2063.9657.8551.16
Book Value[Incl.RevalReserv]/Share (Rs.) 81.4872.2063.9657.8551.16
Revenue From Operations / Share (Rs.) 53.4551.6844.1853.3646.36
PBDIT / Share (Rs.) 13.3610.938.2910.195.75
PBIT / Share (Rs.) 12.3110.007.669.405.16
PBT / Share (Rs.) 12.209.837.559.305.13
Net Profit / Share (Rs.) 9.277.975.986.703.44
NP After MI And SOA / Share (Rs.) 9.277.975.986.703.44
PBDIT Margin (%) 24.9821.1418.7619.0912.39
PBIT Margin (%) 23.0319.3517.3317.6111.13
PBT Margin (%) 22.8219.0117.0917.4211.05
Net Profit Margin (%) 17.3415.4213.5312.557.42
NP After MI And SOA Margin (%) 17.3415.4213.5312.557.42
Return on Networth / Equity (%) 11.3711.049.3411.576.73
Return on Capital Employeed (%) 14.7213.6311.9015.9710.07
Return On Assets (%) 8.769.197.529.075.16
Long Term Debt / Equity (X) 0.000.000.010.010.00
Total Debt / Equity (X) 0.000.030.010.040.00
Asset Turnover Ratio (%) 0.550.620.570.730.71
Current Ratio (X) 4.125.744.674.433.73
Quick Ratio (X) 3.745.254.283.933.22
Inventory Turnover Ratio (X) 7.188.273.733.963.73
Interest Coverage Ratio (X) 121.2364.0278.0197.84155.24
Interest Coverage Ratio (Post Tax) (X) 85.1447.7157.2765.3294.03
Enterprise Value (Cr.) 216.89179.04106.65149.5765.56
EV / Net Operating Revenue (X) 1.931.651.151.330.67
EV / EBITDA (X) 7.727.796.116.985.42
MarketCap / Net Operating Revenue (X) 1.951.611.221.300.77
Price / BV (X) 1.281.160.841.200.70
Price / Net Operating Revenue (X) 1.951.611.221.300.77
EarningsYield 0.080.090.110.090.09

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Alpa Laboratories Ltd. is a Public Limited Listed company incorporated on 18/03/1988 and has its registered office in the State of Madhya Pradesh, India. Company's Corporate Identification Number(CIN) is L85195MP1988PLC004446 and registration number is 004446. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 112.45 Cr. and Equity Capital is Rs. 21.04 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Pharmaceuticals33/2, Pigdamber, A.B.Road, Rau, Indore Madhya Pradesh 453446Contact not found
Management
NamePosition Held
Mr. Mahendra Singh ChawlaChairman
Mr. Paresh ChawlaManaging Director
Mr. Pravin ShahDirector
Mr. Vitthal KothanaDirector
Mr. Shitul ShahDirector
Mrs. Jyoti JainIndependent Director
Mr. Sanket BahetiIndependent Director
Mr. Pratik ShahIndependent Director
Mrs. Pratibha LunawatIndependent Director
Mr. Sunil Kumar ValechaIndependent Director

FAQ

What is the intrinsic value of Alpa Laboratories Ltd and is it undervalued?

As of 09 April 2026, Alpa Laboratories Ltd's intrinsic value is ₹71.07, which is 41.57% higher than the current market price of ₹50.20, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (11.5 %), book value (₹92.0), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Alpa Laboratories Ltd?

Alpa Laboratories Ltd is trading at ₹50.20 as of 09 April 2026, with a FY2026-2027 high of ₹120 and low of ₹46.0. The stock is currently near its 52-week low. Market cap stands at ₹106 Cr..

How does Alpa Laboratories Ltd's P/E ratio compare to its industry?

Alpa Laboratories Ltd has a P/E ratio of 8.95, which is below the industry average of 53.84. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Alpa Laboratories Ltd financially healthy?

Key indicators for Alpa Laboratories Ltd: ROCE of 15.0 % is moderate. Dividend yield is 0.00 %.

Is Alpa Laboratories Ltd profitable and how is the profit trend?

Alpa Laboratories Ltd reported a net profit of ₹20 Cr in Mar 2025 on revenue of ₹110 Cr. Compared to ₹14 Cr in Mar 2022, the net profit shows an improving trend.

Does Alpa Laboratories Ltd pay dividends?

Alpa Laboratories Ltd has a dividend yield of 0.00 % at the current price of ₹50.20. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Alpa Laboratories Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports